$ACRV SEC Filings

Filed On	Filing
26 Oct 2026	Form 4: Miller Mary, Chief Legal Officer Sold 513 shares ($944)
07 Oct 2026	Form 4: Miller Mary, Chief Legal Officer Sold 294 shares ($585)
02 Sep 2026	Form 4: Levin Michaela, Chief Business Officer Received 30,000 shares as a grant or award · Granted 130,000 Stock Option (Right to Buy)
02 Sep 2026	Form 3: Levin Michaela, Chief Business Officer No securities owned
27 Aug 2026	Form 4: Blume-Jensen Peter, Director and 1 other Sold 14,036 shares ($31K)
25 Aug 2026	144
20 Aug 2026	Form 4: Peterson Katharine, Chief Accounting Officer Sold 101 shares ($203)
20 Aug 2026	Form 4: Miller Mary, Chief Legal Officer Sold 185 shares ($372)
20 Aug 2026	Form 4: Gamelin Erick, Chief Development Officer Sold 400 shares ($804)
20 Aug 2026	Form 4: Devroe Eric, Chief Operating Officer Sold 604 shares ($1.21K)
20 Aug 2026	Form 4: Blume-Jensen Peter, Director and 1 other Sold 1,713 shares ($3.44K)
13 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	S-8
12 Aug 2026	10-Q
12 Aug 2026	8-K: Results of Operations and Financial Condition
06 Aug 2026	Form 4: Levy Adam D., Chief Financial Officer Sold 1,142 shares ($1.79K)
23 Jul 2026	Form 4: Miller Mary, Chief Legal Officer Sold 573 shares ($1.01K)
22 Jun 2026	Form 4: Ra Capital MANAGEMENT, L.p., Director and 4 others Granted 20,275 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Tomsicek Michael John, Director Granted 20,275 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Shacham Sharon, Director Granted 20,275 Stock Option (Right to Buy)

Comments